The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Molecular mechanisms involved in cisplatin cytotoxicity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
p73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
Structural aspects of platinum anticancer drug interactions with DNA
Sherman, S. E., & Lippard, S. J. (1987) · Chemical Reviews · doi:10.1021/cr00081a013 · Cited by 930
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
Gong, J., Costanzo, A., Yang, H.-Q., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 930
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Strasser, A. (1994) · Cell · doi:10.1016/0092-8674(94)90201-1 · Cited by 666
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1999) · Nature · doi:10.1038/21704 · Cited by 578
Structural basis for DNA bending by the architectural transcription factor LEF-1
Love, J. J., Li, X., Case, D. A., Giese, K., Grosschedl, R., & Wright, P. E. (1995) · Nature · doi:10.1038/376791a0 · Cited by 573
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., & Lippard, S. J. (1999) · Nature · doi:10.1038/21460 · Cited by 565
Cisplatin and DNA repair in cancer chemotherapy
Zamble, D. B., & Lippard, S. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89095-7 · Cited by 538
Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond, É., Faivre, S. J., WOYNAROWSKI, J. M., & Chaney, S. G. (1998) · PubMed · Cited by 520
Loss of DNA mismatch repair in acquired resistance to cisplatin.
Aebi, S. P., Kurdi-Haidar, B., Gordon, R. T., Cenni, B., Zheng, H., Fink, D. A., Christen, R. D., Boland, C. R., Koi, M., Fishel, R. A., et al. (1996) · PubMed · Cited by 502
Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents
Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., & Kufe, D. W. (1995) · Nature · doi:10.1038/376785a0 · Cited by 485
Werner, M. H., Huth, J. R., Gronenborn, A. M., & Marius Clore, G. (1995) · Cell · doi:10.1016/0092-8674(95)90532-4 · Cited by 465
Dabholkar, M., Vionnet, J., Bostick-Bruton, F., Yu, J. J., & Reed, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117388 · Cited by 446
Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F.-F., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00547-x · Cited by 444
Duckett, D. R., Drummond, J. T., Murchie, A. I., Reardon, J. T., Sancar, A., Lilley, D. M., & Modrich, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6443 · Cited by 421
Three distinct signalling responses by murine fibroblasts to genotoxic stress
Liu, Z.-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., & Wang, J. Y. J. (1996) · Nature · doi:10.1038/384273a0 · Cited by 355
Strathdee, G., MacKean, M. J., Illand, M., & Brown, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202540 · Cited by 350
Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10394 · Cited by 347
Repair of Cisplatin−DNA Adducts by the Mammalian Excision Nuclease
Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., & Lippard, S. J. (1996) · Biochemistry · doi:10.1021/bi960453+ · Cited by 333
Köberle, B., Masters, J. R. W., Hartley, J. A., & Wood, R. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80118-3 · Cited by 300
Drummond, J. T., Anthoney, A., Brown, R., & Modrich, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19645 · Cited by 295
Vaisman, A., Varchenko, M., Umar, A., Kunkel, T. A., Risinger, J. I., Barrett, J. C., Hamilton, T. C., & Chaney, S. G. (1998) · PubMed · Cited by 294
Gelasco, A., & Lippard, S. J. (1998) · Biochemistry · doi:10.1021/bi973176v · Cited by 282
Vassylyev, D. G., Kashiwagi, T., Mikami, Y., Ariyoshi, M., Iwai, S., Ohtsuka, E., & Morikawa, K. (1995) · Cell · doi:10.1016/0092-8674(95)90190-6 · Cited by 266
Lindahl, T., Karran, P., & Wood, R. D. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80124-4 · Cited by 262
RELATIONSHIPS BETWEEN DNA REPAIR AND TRANSCRIPTION
Friedberg, E. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000311 · Cited by 236
Cisplatin induces a persistent activation of JNK that is related to cell death
Sánchez-Perez, I., Murguía, J. R., & Perona, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201578 · Cited by 236
Sorenson, C. M., & Eastman, A. R. (1988) · PubMed · Cited by 224
Pinto, A. L., & Lippard, S. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4616 · Cited by 219
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
Anthoney, A., McIlwrath, A. J., Gallagher, W. M., Edlin, A., & Brown, R. E. (1996) · PubMed · Cited by 210
Ciccarelli, R. B., Solomon, M. J., Varshavsky, A., & Lippard, S. J. (1985) · Biochemistry · doi:10.1021/bi00347a005 · Cited by 205
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin
Mello, J. A., Acharya, S., Fishel, R., & Essigmann, J. M. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90149-0 · Cited by 199
Lemaire, M. A., Schwartz, A., Rahmouni, A. R., & Leng, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1982 · Cited by 197
Ixr1, a Yeast Protein That Binds to Platinated DNA and Confers Sensitivity to Cisplatin
Brown, S. J., Kellett, P. J., & Lippard, S. J. (1993) · Science · doi:10.1126/science.8342024 · Cited by 178
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP
Vichi, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7444 · Cited by 172
Allain, F. H.-T., Yen, Y.-M., Masse, J. E., Schultze, P., Dieckmann, T., Johnson, R. C., & Feigon, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2563 · Cited by 170
Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins
Yamada, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.3.491 · Cited by 161
Telomere loss in cells treated with cisplatin
Ishibashi, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4219 · Cited by 152
Treiber, D. K., Zhai, X., Jantzen, H., & Essigmann, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5672 · Cited by 151
p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
Zamble, D. B., Jacks, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6163 · Cited by 149
Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts
Moggs, J. G., Szymkowski, D. E., Yamada, M., Karran, P., & Wood, R. D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.3.480 · Cited by 132
Cisplatin inhibits synthesis of ribosomal RNA in vivo
Jordan, P., & Carmo‐Fonseca, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.12.2831 · Cited by 130
Self-citation(2009) · CRC Press eBooks · doi:10.3109/9780203092897 · Cited by 123
Cockayne syndrome: defective repair of transcription?
van Gool, A. J., van der Horst, G. T. J., Citterio, E., & Hoeijmakers, J. H. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4155 · Cited by 116
Allday, M. J., Inman, G. J., Crawford, D., & Farrell, P. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00182.x · Cited by 110
Recognition of DNA alterations by the mismatch repair system
Marra, G., & Schär, P. (1999) · Biochemical Journal · doi:10.1042/bj3380001 · Cited by 102
Mello, J. A., Lippard, S. J., & Essigmann, J. M. (1995) · Biochemistry · doi:10.1021/bi00045a020 · Cited by 101
Zhai, X., Beckmann, H., Jantzen, H., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi981708h · Cited by 100
Durant, S. T., Morris, M. M., Illand, M., McKay, H. J., McCormick, C., Hirst, G. L., Borts, R. H., & Brown, R. E. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80047-5 · Cited by 100
Zlatanova, J. S., Yaneva, J. N., & Leuba, S. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.791 · Cited by 99
Corda, Y., Job, C., Anin, M. F., Leng, M., & Job, D. (1991) · Biochemistry · doi:10.1021/bi00215a032 · Cited by 91
Lack of transcription-coupled repair in mammalian ribosomal RNA genes
Christians, F. C., & Hanawalt, P. C. (1993) · Biochemistry · doi:10.1021/bi00090a030 · Cited by 89
Identification of p53 genetic suppressor elements which confer resistance to cisplatin
Gallagher, W. M., Cairney, M., Schott, B., Roninson, I. B., & Brown, R. H. (1997) · Oncogene · doi:10.1038/sj.onc.1200813 · Cited by 83
Trimmer, E. E., Zamble, D. B., Lippard, S. J., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi971675q · Cited by 78
Turchi, J. J., & Henkels, K. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13861 · Cited by 66
Vos, J. H., & Wauthier, E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2245 · Cited by 65
Mymryk, J. S., Zaniewski, E., & Archer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2076 · Cited by 54
Coin, F., Frit, P., Viollet, B., Salles, B., & Egly, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3907 · Cited by 45
Repair of UV Damage in Actively Transcribed Ribosomal Genes
Fritz, L. K., & Smerdon, M. J. (1995) · Biochemistry · doi:10.1021/bi00040a024 · Cited by 45
Hoffmann, J., Pillaire, M., Lesca, C., Burnouf, D., Fuchs, R. P., Defais, M. J., & Villani, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13766 · Cited by 45
Fleck, O., Kunz, C., Rudolph, C., & Kohli, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30398 · Cited by 27
DNA adducts of cisplatin, transplatin and platinum-intercalating drugs.
Leng, M., & Brabec, V. (1994) · PubMed · Cited by 26
Cited by
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Florea, A.-M., & Büsselberg, D. (2011) · Cancers · doi:10.3390/cancers3011351 · Cited by 1,759
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Fuertes, M. A., Alonso, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 893
Systems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
Metadata
- Authors
- Jordan, P., & Carmo-Fonseca*, M.
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2000-08
- Volume
- 57
- Issue
- 8
- Pages
- 1229-1235
- ISSN
- 1420-682X (ISSN-L)
- OpenAlex
- W2043497955
- Cited by
- 398
- References
- 64
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.